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In this issue of Critical Care, Patschan and colleagues [1] 
present a study of endothelial progenitor cells (EPCs) in 
patients with sepsis. Th   e data convincingly demonstrate 
that the levels of circulating EPCs in septic patients are 
elevated and that this phenomenon is independent of the 
presence of acute renal failure. Moreover, the functional 
competence of circulating EPCs, as judged by the 
clonogenic assay, is reduced in sepsis, whereas the levels 
of circulating pro-angiogenic or EPC-mobilizing factors 
(like vascular endothelial growth factor, stem cell-derived 
factor-1, and angiopoietin-2) or both are higher in sepsis 
than in the control healthy population. It is my belief that 
the importance of this study is in focusing attention on 
several frequently ignored aspects of sepsis. Th  ese are 
detailed below.
Systemic macrovasculopathy manifesting as a drop in 
blood pressure has attracted much attention. By com-
parison, the phenomenon of microvascular dysfunction, 
which is potentially responsible for profound metabolic 
perturbations at the tissue level, is more surreptitious, 
despite the fact that it is responsible for the eventual 
multi-organ failure [2]. By most accounts, sepsis-induced 
develop  ment of vasculopathy is signiﬁ  cantly hampered 
by the default response to stress: mobilization of stem 
and progenitor cells that, in part, restore damaged vascu-
la  ture [3]. By extension, a physician should be alerted to 
the fact and be alarmed when a septic patient does not 
boost the number of circulating EPCs. Th   is can occur in 
patients with a preexisting chronic cardiovascular or 
renal disease or in older patients and, in any of these 
cases, could result in the exhaustion of a pool of readily 
recruitable EPCs. Th  is prediction will require future 
detailed analysis of the causes and consequences of the 
hampered surge in circulating EPCs.
Regenerative capacity and the dissociation between the 
numerical value and clonogenic competence represent 
the crux of the problem in sepsis. Reactive oxygen 
species,  pro in ﬂ   ammatory cytokines and chemokines, 
adrenergic stimu  lation, and other factors compromise 
various aspects of stem cell functions, their mobilization, 
niche properties, engraftment, and signaling, all of which 
result in the exhaustion of the EPC pool or incompetence 
of EPCs or both [4]. In addition, aging is the most 
common cause of stem cell dysfunction [5]. Th  erefore, 
the end result of the numerical and clonogenic 
dissociation of stem cell response to sepsis, the proverbial 
vox clamantis in deserto, is a complex integral of their 
quantity and quality. Hence, one of the potential clinical 
goals could be restoring stem cell competence.
While the fact of sepsis-induced mobilization of EPCs 
does not seem to cause dispute [6], the deﬁ  nition of EPCs 
and the signiﬁ  cance of their recruitment are contentious 
subjects. Th  e origins of these cells, their homogeneity, 
and identiﬁ  cation markers are but a few unsettled issues 
as discussed by the authors, who in the midst of the 
existing debates have elected rational strategies to assess 
EPCs numerically and functionally. What I perceive as an 
even more serious challenge, however, is the fact that, 
along the path(s) from the quiescence of a niche environ-
ment to the re-programming signals in the circulation 
and target tissues, these cells are continuously changing 
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ment provides but a snapshot of rapidly changing events 
in the context of evolving pathophysiological presenta-
tions of sepsis. It is necessary to perform fate tracing of 
various stem and progenitor cells in experimental 
animals subjected to a model of sepsis to gain insights 
into the pathways from niches to tissues, expression of 
various markers, and potential bifurcations along the 
path in order to test the validity of such ﬁ  ndings  in 
human disease.
I hope that the authors, having demonstrated EPC 
responses to sepsis, will conduct longitudinal numerical 
and functional testing of EPCs with the concomitant 
analysis of clinical presentations and outcomes in a large 
cohort of patients with sepsis. It is important to examine 
EPC responses in septic patients of various ages, in males 
and females, in patients with a preexisting chronic kidney 
or cardiovascular disease and those without them, and in 
patients who are immune-competent and those who are 
not.
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